000 03365cam a2200541Ii 4500
001 on1029740839
003 OCoLC
005 20221128213615.0
006 m d
007 cr cn|||||||||
008 180328s2019 paua obf 001 0 eng d
040 _aLGG
_beng
_erda
_epn
_cLGG
_dUAB
_dOCLCO
_dCASUM
_dOCLCQ
_dOCLCF
_dOCLCA
_dCUX
_dN$T
019 _a1039687034
020 _a9781496367099
_q(electronic bk.)
020 _a149636709X
_q(electronic bk.)
020 _z1496347447
020 _z9781496347442
035 _a2112278
_b(N$T)
035 _a(OCoLC)1029740839
_z(OCoLC)1039687034
060 4 _aWD 101
072 7 _aHEA
_x039000
_2bisacsh
072 7 _aMED
_x014000
_2bisacsh
072 7 _aMED
_x022000
_2bisacsh
072 7 _aMED
_x112000
_2bisacsh
072 7 _aMED
_x045000
_2bisacsh
049 _aMAIN
130 0 _aDyslipidemia (Myerson)
245 1 0 _aDyslipidemia :
_ba clinical approach
_c
_h[E-Book]
263 _a1712
264 1 _aPhiladelphia :
_bWolters Kluwer,
_c[2019]
300 _a1 online resource :
_billustrations
336 _atext
_2rdacontent
337 _acomputer
_2rdamedia
338 _aonline resource
_2rdacarrier
588 _aDescription based on print version record.
504 _aIncludes bibliographical references and index.
520 _a"Dyslipidemia: A Clinical Approach is intended as a low-cost, quick-reference, easy-to-navigate guide for a broad range of healthcare professionals that will provide high-yield decision-making tools to ensure confidence in patient treatment and management of those who are suffering from a lipids disorder or related disease. Content will include detailed drug tables, information on important drug interactions, and also non-statin alternatives for those patients who cannot tolerate statins. In addition, decision-making algorithms and careful patient management plans will be included to ensure quicker and more effective treatment and management of patients"--Provided by publisher.
505 0 _a1. A historical perspectives on lipids and cardiovascular disease -- 2. Basic lipid and lipoprotein biochemistry for clinical lipidologists -- 3. Guidelines and risk scores -- 4. Lipid measurement -- 5. Step-by-step diagnosis and management plan -- 6. Lifestyle modification in the management of dyslipidemia -- 7. Lipid medications overview: prescription and nonprescription preparations -- 8. Statins -- 9. Nonstain medications: omega-3 fatty acids, fibrates, bile acid sequestrants, niacin, and cholesterol absorption inhibitors -- 10. Hypertriglyceridemia -- 11. Safety and tolerability of lipid-lowering medications -- 12. Familial hypercholesterolemia: family disease -- 13. Complex dyslipidemias -- 14. Children and adolescents step-by-step evaluation and management plan -- 15. Lipid management in special populations.
590 _aAdded to collection customer.56279.3
650 1 2 _aDyslipidemias
_xdiagnosis.
650 2 2 _aDyslipidemias
_xtherapy.
650 0 _aLipids
_xMetabolism
_xDisorders.
700 1 _aMyerson, Merle,
_eeditor.
856 4 0 _uhttps://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=2112278
_yKingston Hospital NHS Foundation Trust OpenAthens account holders click here for access
938 _aEBSCOhost
_bEBSC
_n2112278
942 _n0
994 _a92
_bN$T
999 _c93293
_d93293